These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14616301)

  • 1. Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS < or = 3.5.
    Ruggieri RM; Palermo R; Vitello G; Gennuso M; Settipani N; Piccoli F
    Acta Neurol Scand; 2003 Nov; 108(5):323-6. PubMed ID: 14616301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
    Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
    BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive impairment in patients with relapsing-remitting multiple sclerosis. The correlation with MRI lesion volume.
    Karlińska I; Siger M; Lewańska M; Selmaj K
    Neurol Neurochir Pol; 2008; 42(5):416-23. PubMed ID: 19105110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
    Cogo MG; Rota S; Fusco ML; Mapelli C; Ferri F; Appollonio IM; Isella V
    J Clin Exp Neuropsychol; 2014; 36(10):1066-75. PubMed ID: 25486588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropsychology of mildly disabled patients with relapsing-remitting multiple sclerosis].
    Santiago Rolanía O; Guàrdia Olmos J; Arbizu Urdiain T
    Psicothema; 2006 Feb; 18(1):84-7. PubMed ID: 17296014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different cognitive profiles of Brazilian patients with relapsing-remitting and primary progressive multiple sclerosis.
    Rodrigues DN; Paes RA; Vasconcelos CC; Landeira-Fernandez J; Alvarenga MP
    Arq Neuropsiquiatr; 2011 Aug; 69(4):590-5. PubMed ID: 21877025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
    Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
    J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
    Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
    Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
    Lozano-Soto E; Cruz-López ÁJ; Gutiérrez R; González M; Sanmartino F; Rashid-Lopez R; Espinosa-Rosso R; Forero L; González-Rosa JJ
    Arch Clin Neuropsychol; 2021 May; 36(4):475-484. PubMed ID: 33067616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression and cognitive impairment in disability-free early multiple sclerosis.
    Haase CG; Tinnefeld M; Lienemann M; Ganz RE; Faustmann PM
    Behav Neurol; 2003; 14(1-2):39-45. PubMed ID: 12719637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PASAT in detecting cognitive impairment in relapsing-remitting MS.
    Rosti E; Hämäläinen P; Koivisto K; Hokkanen L
    Appl Neuropsychol; 2007; 14(2):101-12. PubMed ID: 17523884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions.
    Gajofatto A; Turatti M; Bianchi MR; Forlivesi S; Gobbin F; Azzarà A; Monaco S; Benedetti MD
    Acta Neurol Scand; 2016 Mar; 133(3):183-91. PubMed ID: 26009804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS)].
    Leclercq E; Cabaret M; Guilbert A; Jougleux C; Vermersch P; Moroni C
    Geriatr Psychol Neuropsychiatr Vieil; 2014 Sep; 12(3):331-8. PubMed ID: 25245320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.